Trek-Segafredo suspend Pantano after EPO positive

Jarlinson Pantano (Trek-Segafredo)

Trek-Segafredo announced on Monday that they have suspended Colombian Jarlinson Pantano after the 30-year-old was informed of an adverse analytical finding for the blood boosting drug Erythropoietin (EPO) in an out-of-competition doping control carried out on February 26 by the Cycling Anti-Doping Foundation. "It is with deep disappointment that we have just learned that our rider, Jarlinson Pantano, has been notified of an adverse analytical finding in a sample collected during an out of competition control carried out by the Cycling Antidoping Foundation. In accordance with our zero-tolerance policy, he has been suspended immediately," Trek-Segafredo announced in a statement sent to media. "We hold our riders and staff to the highest ethical standards and will act and communicate accordingly as more details become available." Pantano last raced for Trek-Segafredo on March 25 when he dropped out of the opening stage of the Volta a Catalunya. EPO use peaked in the ...

Read on Cycling News


More Like This

Card image cap

Pantano returns adverse finding for EPO, suspended by Trek-Segafredo

View
Card image cap

Pantano suspended after EPO finding

View
Card image cap

Pantano 'waiting, wishing' for doping case to be resolved

View
Card image cap

Pantano suspended after EPO positive

View
Card image cap

Jarlinson Pantano retires from cycling amid EPO postive

View
Card image cap

Pantano provisionally suspended for EPO

View
Card image cap

Pantano announces retirement in wake of EPO positive

View
Card image cap

Bahrain-Merida drops Kanstantsin Siutsou for AAF

View
Card image cap

Manzana Postobon team to be suspended after second adverse analytical finding

View
Card image cap

Manzana Postobon triggers UCI’s team suspension rule after second positive test

View